← Leaderboards
Richard Noel McLaughlin
Pacific Northwest Research Institute
$3,951,902
Attributed
$3,951,902
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $845.5K · FY2015–25$1M$750K$500K$250K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,951,902 · 4
By mechanism
R35$2,518,902 · 1
R00$747,000 · 1
R21$506,000 · 1
K99$180,000 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Human Genome”
- Richard A Gibbs · Baylor College Of Medicine$646,091,503
- Eric S Lander · Whitehead Institute For Biomedical Res$621,542,043
- Richard K. Wilson · Washington University$500,614,854
- Stacey Gabriel · Massachusetts Institute Of Technology$205,436,993
- Robert H Waterston · Washington University$164,835,786
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$154,368,853
Research focus
Human GenomeIn VitroGenomeRecording Of Previous EventsMutationVariantRetroelementsPressureComparative GenomicsElementsGeneticMalignant NeoplasmsInterestBiologyAutoimmune DiseasesEvolutionAutoimmunityBindingGenetic DiseasesExperimental StudyGenome AnalysisProspectiveInnate Immune SystemProteins
Grant awards (15)
Leveraging natural and directed evolution to dissect the functional consequences of sequence variation in human L1 retrotransposons$460,000
R35 · FY2025 · GM · contact PI
Leveraging natural and directed evolution to dissect the functional consequences of sequence variation in human L1 retrotransposons$9,121
R35 · FY2025 · GM · contact PI
Leveraging natural and directed evolution to dissect the functional consequences of sequence variation in human L1 retrotransposons$460,000
R35 · FY2024 · GM · contact PI
Reverse transcriptase-mediated expansion of the host innate immune system$276,000
R21 · FY2024 · AI · contact PI
Leveraging natural and directed evolution to dissect the functional consequences of sequence variation in human L1 retrotransposons$109,451
R35 · FY2024 · GM · contact PI
Leveraging natural and directed evolution to dissect the functional consequences of sequence variation in human L1 retrotransposons$460,000
R35 · FY2023 · GM · contact PI
Reverse transcriptase-mediated expansion of the host innate immune system$230,000
R21 · FY2023 · AI · contact PI
Leveraging natural and directed evolution to dissect the functional consequences of sequence variation in human L1 retrotransposons$100,330
R35 · FY2023 · GM · contact PI
Leveraging natural and directed evolution to dissect the functional consequences of sequence variation in human L1 retrotransposons$460,000
R35 · FY2022 · GM · contact PI
Leveraging natural and directed evolution to dissect the functional consequences of sequence variation in human L1 retrotransposons$460,000
R35 · FY2021 · GM · contact PI
Causes and human health consequences of the evolution of retroelements and host restriction factors$249,000
R00 · FY2020 · GM · contact PI
Causes and human health consequences of the evolution of retroelements and host restriction factors$249,000
R00 · FY2019 · GM · contact PI
Causes and human health consequences of the evolution of retroelements and host restriction factors$249,000
R00 · FY2018 · GM · contact PI
Causes and human health consequences of the evolution of retroelements and host restriction factors$90,000
K99 · FY2016 · GM · contact PI
Causes and human health consequences of the evolution of retroelements and host restriction factors$90,000
K99 · FY2015 · GM · contact PI